International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 395 participants.
Also called NCT02656329
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 395 participants
- Sponsor
- Registry
-
NCT02656329 -
2015-001464-19
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Canada, Czechia, France, Germany, Hungary, Italy, Netherlands, Poland, Spain
- Registry status
- Terminated
Technical summary
Registry record NCT02656329. Randomized; no masking; primary purpose prevention. Start 2015-12-30 (actual); primary completion 2018-05-04 (actual). Results posted on 2019-05-22.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
- Acronym
- ADMIRE-ICD
- Condition
- Heart Failure
- Intervention (Drug)
- Iobenguane I -123 Injection
- Intervention (Device)
- Implantable Cardioverter Defibrillator
- Intervention (Drug)
- Thyroid blocking
- Intervention (Drug)
- Iobenguane I -123 Injection
- Intervention (Device)
- Implantable Cardioverter Defibrillator
- Lead sponsor
- GE Healthcare
- Collaborator
- Advanced Clinical, LLC
- Collaborator
- TFS
- Collaborator
- H2O Clinical LLC
- Collaborator
- AG Mednet
- Collaborator
- ICON plc
- Collaborator
- ABX CRO
- Collaborator
- TransPerfect
Record details
- Record id
cardio:ct-nct02656329- Content hash
13d54f9c4fafa3dd8215c257eba6822b6a3e7b6c495442aab769c568f39888a0